Broadcom Eyes $35 Billion AI Chip Financing Deal With Apollo and Blackstone 
Is dark chocolate healthier than milk chocolate? 2 dietitians explain 
US Stock Futures Slip as Trump Rejects Iran Peace Proposal Amid Rising Middle East Tensions 
Rubio Discusses Iran Crisis and Strait of Hormuz Disruptions With UK and Australia 
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
Indian Stock Market Drops as Iran Conflict Fuels Oil Price and Inflation Fears 
US Auto Industry Urges Trump to Block Chinese EV Market Access 
Asian Stocks Rise Despite Middle East Tensions as Chipmakers Boost Markets 
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes 
Asian Stocks Slip as Korea’s KOSPI Tumbles Amid Iran Conflict and Chip Sector Profit-Taking 
Ibiden Stock Surges as AI Chip Demand Boosts Profit Outlook 
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint 
AWS Data Center Overheating Disrupts Cloud Services in Northern Virginia 
Drugmakers including Pfizer Inc, GlaxoSmithKline PLC , Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA will raise prices in the US on over 350 unique drugs in early January.
The increases are in preparation for the Inflation Reduction Act (IRA), which allows the government's Medicare health program to negotiate prices for some drugs starting in 2026.
The pharmaceutical industry is also dealing with inflation and supply chain constraints that increased manufacturing costs.
The price hikes are based on list prices, which do not account for other discounts or rebates to pharmacy benefit managers.
According to data released by 46brooklyn, a drug pricing non-profit affiliated with 3 Axis, drugmakers increased prices on more than 1,400 pharmaceuticals in 2022. Since 2015, there have been the most rises.
According to Antonio Ciaccia, president of 3 Axis, drugmakers have concentrated on releasing their medications at higher prices due to the concentration on annual price hikes.
More drug prices are likely to be announced over the course of January - historically the biggest month for drugmakers to raise prices.
Pfizer has so far disclosed the biggest price hikes, with 89 different prescription names seeing a rise in price in addition to an extra 10 drug brands at its Hospira division.
Then came GSK, which has already announced hikes for 26 different medications, including nearly a 7% rise for its well-known shingles vaccine Shingrix.
